Legal & General Group
AGRX

Legal & General Group’s Agile Therapeutics AGRX Stock Holding History

Legal & General Group’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4
Closed -$17K – 3708
2021
Q1 		$17K Hold
4
– – ﹤0.01% 3197
2020
Q4 		$23K Hold
4
– – ﹤0.01% 3047
2020
Q3 		$24K Sell
4
-2
-33% -$11.5K ﹤0.01% 2929
2020
Q2 		$31K Buy
+6
New +$31.2K ﹤0.01% 2885
2017
Q2 		– Sell
-2
Closed -$10K – 3399
2017
Q1 		$10K Hold
2
– – ﹤0.01% 3197
2016
Q4 		$17K Buy
+2
New +$28K ﹤0.01% 3147

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return